106 related articles for article (PubMed ID: 16846649)
1. Inhibition of hepatitis B virus by D-fraction from Grifola frondosa: synergistic effect of combination with interferon-alpha in HepG2 2.2.15.
Gu CQ; Li J; Chao FH
Antiviral Res; 2006 Nov; 72(2):162-5. PubMed ID: 16846649
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus sensitivity to interferon-α in hepatocytes is more associated with cellular interferon response than with viral genotype.
Shen F; Li Y; Wang Y; Sozzi V; Revill PA; Liu J; Gao L; Yang G; Lu M; Sutter K; Dittmer U; Chen J; Yuan Z
Hepatology; 2018 Apr; 67(4):1237-1252. PubMed ID: 29059468
[TBL] [Abstract][Full Text] [Related]
3. Anti-hepatitis B virus activity and mechanisms of recombinant human serum albumin-interferon-alpha-2b fusion protein in vitro and in vivo.
Bingfa X; Qinglin F; Hui H; Canjun W; Wei W; Lihua S
Pharmacology; 2009; 83(6):323-32. PubMed ID: 19407486
[TBL] [Abstract][Full Text] [Related]
4. Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells.
Hagelstein J; Kist A; Stremmel W; Galle PR
Arzneimittelforschung; 1998 Mar; 48(3):343-7. PubMed ID: 9553691
[TBL] [Abstract][Full Text] [Related]
5. The response to interferon is influenced by hepatitis B virus genotype in vitro and in vivo.
Zhang Y; Wu Y; Ye S; Wang T; Zhao R; Chen F; Abe K; Jin X
Virus Res; 2013 Jan; 171(1):65-70. PubMed ID: 23123214
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the replication of hepatitis B virus in vitro by oxymatrine.
Lin M; Yang LY; Li WY; Peng YP; Zheng JK
J Int Med Res; 2009; 37(5):1411-9. PubMed ID: 19930845
[TBL] [Abstract][Full Text] [Related]
7. Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replication.
Lutgehetmann M; Volzt T; Quaas A; Zankel M; Fischer C; Dandri M; Petersen J
Antivir Ther; 2008; 13(1):57-66. PubMed ID: 18389899
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
[TBL] [Abstract][Full Text] [Related]
9. The anti-HBV effect mediated by a novel recombinant eukaryotic expression vector for IFN-α.
Yu H; Hou Z; Han Q; Zhang C; Zhang J
Virol J; 2013 Aug; 10():270. PubMed ID: 23984795
[TBL] [Abstract][Full Text] [Related]
10. In vitro resistance to interferon-alpha of hepatitis B virus with basic core promoter double mutation.
Wang Y; Wei L; Jiang D; Cong X; Fei R; Chen H; Xiao J; Wang Y
Antiviral Res; 2007 Aug; 75(2):139-45. PubMed ID: 17397939
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha and interferon-gamma inhibit synergistically viral replication in hepatitis B virus-replicating cells.
Kawanishi Y; Hayashi N; Katayama K; Ueda K; Takehara T; Miyoshi E; Mita E; Kasahara A; Fusamoto H; Kamada T
J Med Virol; 1995 Nov; 47(3):272-7. PubMed ID: 8551280
[TBL] [Abstract][Full Text] [Related]
12. The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion.
Yan R; Zhao X; Cai D; Liu Y; Block TM; Guo JT; Guo H
J Virol; 2015 Sep; 89(18):9200-12. PubMed ID: 26109732
[TBL] [Abstract][Full Text] [Related]
13. [Based on the low-density cDNA Macroarray for screening of antiviral proteins of IFNa tissues].
Guan SH; Yang K; Wang J; Cheng ZL; Pan Y; Wu YY; Yang DL
Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):774-8. PubMed ID: 22409852
[TBL] [Abstract][Full Text] [Related]
14. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication.
Yang J; Bo XC; Ding XR; Dai JM; Zhang ML; Wang XH; Wang SQ
J Viral Hepat; 2006 Mar; 13(3):158-65. PubMed ID: 16475991
[TBL] [Abstract][Full Text] [Related]
15. Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection.
Marinos G; Naoumov NV; Williams R
Hepatology; 1996 Nov; 24(5):991-5. PubMed ID: 8903365
[TBL] [Abstract][Full Text] [Related]
16. [IFN-alpha-induced gp96 upregulation negatively affects the anti-HBV efficiency of IFN-alpha].
Gao Y; Fan H; Qiu L; Meng S
Wei Sheng Wu Xue Bao; 2013 Aug; 53(8):867-74. PubMed ID: 24341279
[TBL] [Abstract][Full Text] [Related]
17. Thymosin-alpha 1, but not interferon-alpha, specifically inhibits anchorage-independent growth of hepatitis B viral transfected HepG2 cells.
Moshier JA; Mutchnick MG; Dosescu J; Holtz TK; Akkary S; Mahakala K; Merline JR; Naylor PH
J Hepatol; 1996 Dec; 25(6):814-20. PubMed ID: 9007707
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect on hepatitis B virus in vitro by a peroxisome proliferator-activated receptor-gamma ligand, rosiglitazone.
Wakui Y; Inoue J; Ueno Y; Fukushima K; Kondo Y; Kakazu E; Obara N; Kimura O; Shimosegawa T
Biochem Biophys Res Commun; 2010 May; 396(2):508-14. PubMed ID: 20430009
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of hepatitis B virus replication by targeting ribonucleotide reductase M2 protein.
Liu X; Xu Z; Hou C; Wang M; Chen X; Lin Q; Song R; Lou M; Zhu L; Qiu Y; Chen Z; Yang C; Zhu W; Shao J
Biochem Pharmacol; 2016 Mar; 103():118-28. PubMed ID: 26774458
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the replication of hepatitis B virus in vitro by emodin.
Shuangsuo D; Zhengguo Z; Yunru C; Xin Z; Baofeng W; Lichao Y; Yan'an C
Med Sci Monit; 2006 Sep; 12(9):BR302-6. PubMed ID: 16940925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
